Recurrent Ovarian Germ Cell Tumor Terminated Phase 2 Trials for Palifosfamide (DB05668)

IndicationStatusPhase
DBCOND0029793 (Recurrent Ovarian Germ Cell Tumor)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01808534Palifosfamide in Treating Patients With Recurrent Germ Cell TumorsTreatment